Stroke prevention in sickle cell disease

Current Opinion in Hematology

Volumn 7, Issue 2, 2000, Pages 101-105

  Adams, Robert J ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CEREBROVASCULAR DISEASE; CHILD; HEMOGLOBINOPATHY; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SICKLE CELL ANEMIA; STROKE;

ADOLESCENT; ADULT; CEREBROVASCULAR ACCIDENT; CHILD; CHILD, PRESCHOOL; HEMOGLOBIN SC DISEASE; HUMANS; INTRACRANIAL HEMORRHAGES; RISK FACTORS;

EID: 0033954285     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200003000-00005     Document Type: Article

References (24)

1. 1 Greer M, Schotland D: Abnormal hemoglobin as a cause of neurologic disease. Neurol 1962, 12:114-123.
2. 2 Adams RJ, Nichols FT: Sickle cell anemia, sickle cell trait and thalassemia. In Handbook of Clinical Neurology, Vascular Diseases-III, vol 11. Edited by Vinken PJ, Bruyn GW, Klawans HL. New York, NY: Elsevier Science Publications; 1989:503-515.
3. 3 Steinberg MH: Management of sickle cell disease. N Engl J Med 1999, 340:1021-1030.
4. 4 Frempong KO, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, et al.: Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 1998,91:288-294.
5. 5 Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al.: Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998, 339:5-11.
6. 6 Adams RJ, McKie V, Nichols FT, Carl EM, Zhang DL, McKie K, et al.: The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992, 326:605-610.
7. 7 Adams RJ, McKie VC, Carl EM, Nichols FT, Perry R, Brock K, et al.: Long term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 1997, 42:699-704.
8. 8 Wayne AS, Kevy SV, Nathan DG: Transfusion management of sickle cell disease. Blood 1993, 81:1109-1123.
9. 9 Armstrong FD, Thompson RJ Jr, Wand W, Zimmerman R, Pegelow CH, Miller S, et al.: Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Neuropsychological Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics 1996, 97:864-870.
10. 10 Seabird J, Glasier C, Kirby R, Allison J, James C, Becton D, et al.: Transcranial Doppler (TCD), MA and MRI as a screening examination for cerebrovascular disease in patients with sickle cell anemia-an eight year study. Pediatr Radiol 1998, 28:138-142.
11. 11 Pavlakis SG: Neurologic complications of sickle cell disease. Adv Pediatr 1989, 36:247-76.
12. 12 Moser FG, Miller ST, Bello JA, Pegelow CH, Zimmerman RA, Wang WC, et al.: The spectrum of brain MR abnormalities in sickle cell disease: a report from the cooperative study of sickle cell disease. AJNR Am J Neuroradiol 1996, 17:965-972.
13. 13 Tam D: Protein C and protein S activity in sickle cell disease and stroke. Journal of Child Neurology 1997, 12:19-21.
14. 14 Houston PE, Rana S, Sekhsaria S, Perlin E, Kim KS, Castro OL: Homocysteine in sickle cell disease: relationship to stroke. Am J Med 1997, 103:192-196.
15. 15 French JA, Kenny D, Scott JP, Hoffmann RG, Wood JD, Hudetz AG, Hillery CA: Mechanisms of stroke in sickle cell disease: sickle erythrocytes decrease cerebral blood flow in rats after nitric oxide synthase inhibition. Blood 1997, 89:4591-4599.
16. 16 Steen GR, Xiong X, Mulhern RK, Langston JW, Wang WC: Subtle brain abnormalities in children with sickle cell disease: relationship to blood hematocrit. Ann Neurol 1998, 45:279-286.
17. 17 Powers DR, Conti PS, Wong W-Y, Groncy P, Hyman C, Smith E, et al.: Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography. Blood 1999, 93:71-79.
18. 18 Reed W, Jagust W, Al-Mateen M, Vichinsky E: Role of positron emission tomography in determining the extent of cns ischemia in patients with sickle cell disease. Am J Hematol 1999, 60:268-272.
19. 19 Walters MC, Sullivan KM, Bernaudin F, Souillet G, Vannier JP, Lenarsky C, et al.: Neurological complications after allogenic bone marrow transplantation for sickle cell anemia. Blood 1995, 85:879-884.
20. 20 Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al.: Effect of hydroxyurea on frequency of painful crises in sickle cell anemia. N Engl J Med 1995, 332:1317-1322.
21. 21 Ware RE, Zimmerman SA, Schultz WH: Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease. Blood 1999, 94:3022-3026.
22. 22 Rana S, Houston, P, Surana N, Shalaby-Rana E, Castro O: Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke. J Pediatr 1997, 131:757-760.
23. 23 Vernet O, Montes JL, O'Gorman AM, Baruchel S, Farmer JP: Encephaloduroarterio-synangiosis in a child with sickle cell anemia and moyamoya disease. Pediatr Neurology 1996, 14:226-230.
24. 24 National Heart, Lung, and Blood Institute: Clinical alert. Bethesda, MD: National Heart, Lung, and Blood Institute: Department of Health & Human Services; Sept 18, 1997.